Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle systems are being engineered to better mimic natural hair follicles for studying hair disorders and testing treatments.

Stem cell therapies are advancing quickly with new technologies and need supportive regulations for clinical use.

Low vitamin D levels may worsen or cause alopecia areata.

Targeting androgen receptors in the skin is the most effective treatment for hyperandrogenism-related skin issues.

MSC-derived EVs have potential as therapeutic agents but face challenges like production complexity and high costs.

Nanotechnology could improve treatment for scars and atopic dermatitis by targeting skin issues more effectively.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

FFA has higher long-term remission rates than LPP.

Regulatory T cells help heal skin wounds by reducing inflammation and promoting tissue repair.

Vitiligo treatment requires a personalized mix of therapies to restore skin color and improve life quality.

The gel is safe and effective for treating oral mucositis from chemotherapy and radiation.

Vitiligo is influenced by genetics and environment, and combining these factors can improve early detection and prevention.

Triamcinolone acetonide is more effective than cryotherapy for hair regrowth in alopecia areata but has different side effects.

Wedelolactone may help treat inflammation, infections, cancer, bone loss, and organ damage.

Icariin can regulate macrophages and may help treat inflammation, cancer, bone disorders, and fibrotic diseases.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Flammulina velutipes polysaccharide helps the immune system fight tumors by activating certain pathways.

PRP shows promise for hair restoration with mild side effects, but more research is needed for clear guidelines.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Nanotechnology shows promise in improving hair loss treatments by enhancing drug delivery and reducing side effects.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Gut microbiota and metabolic pathways may play a key role in PCOS development.

Inorganic nanoparticle-based scaffolds can improve wound healing by fighting bacteria and helping tissue grow.

A new microneedle patch helps repair spinal cord injuries by reducing scarring and promoting nerve growth.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Understanding different types of hair loss helps in accurate diagnosis and treatment.

Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.

BMS-470539 reduces skin fibrosis and inflammation.